Definition
Label laws are statutory requirements compelling manufacturers, sellers, or patent holders to affix specified information to goods, products, or patented articles as a condition of legal protection or market authorization. The term encompasses two historically distinct regulatory contexts:
1. Patent marking requirements: Laws requiring patentees to mark patented goods with notice of the patent (including the word "patented" and the grant date) as a precondition for recovering damages in infringement suits. Failure to mark shifts the burden onto the patent holder to prove the infringer received actual notice before damages accrue.
2. Consumer product and regulatory labeling: Statutory schemes — most prominently under federal food, drug, and cosmetic law — requiring that products bear accurate, government-specified disclosures about contents, warnings, approved uses, and manufacturer identity. Mislabeling or omission of required information can constitute a violation independent of any underlying product defect.
In modern usage, "label laws" appears most frequently in regulatory law literature dealing with food safety, pharmaceutical approval, and agricultural products, though the patent marking sense remains operative in intellectual property practice.
---
Common Language
Modern common usage (Wiktionary): "Label" in ordinary English refers to a slip of paper or material attached to an object identifying or describing it, or more broadly, any classifying designation applied to a person or thing.
Historical common usage (Webster's 1913): A label is a slip of ribbon, paper, or parchment affixed to anything and containing a title or description; also, a narrow strip appended to a document.
The legal gap is significant. In common usage, a label is purely descriptive and voluntary. In regulatory and IP law, a label is a legally mandated instrument carrying specific content requirements — its absence or inaccuracy triggers liability, forfeits legal protections, or bars market entry entirely. The ordinary intuition that a label is merely informational drastically underestimates its legal function.
---
Common Confusion
Label laws are sometimes conflated with broader product liability or consumer protection statutes. The distinction matters: label law violations are regulatory offenses tied to omission or inaccuracy of required disclosures, and can arise even when the underlying product is safe and unadulterated. A manufacturer may comply fully with product safety standards and still violate a label law by failing to include mandated language, and vice versa. In patent contexts, the labeling requirement is a procedural prerequisite to damages — not a substantive infringement question — which researchers sometimes overlook when evaluating patent enforcement remedies.
---
Why It Matters in Research
The Bouvier entry captures only the patent marking dimension of label laws, reflecting the state of federal statutory law in the early 1870s. Researchers using historical legal dictionaries as a starting point will find the pharmaceutical and food labeling dimension entirely absent — that regulatory apparatus emerged with the Pure Food and Drug Act of 1906 and expanded dramatically through the Federal Food, Drug, and Cosmetic Act of 1938 and subsequent amendments. Any research project that relies on pre-twentieth-century dictionary definitions of "label laws" will miss the regulatory core of what the term means in modern practice.
The patent marking rule described in Bouvier remains substantively alive in current U.S. patent law, but the statutory framework has been amended and recodified. The Bouvier entry references the Act of July 8, 1870 — researchers should trace this through subsequent patent statutes to the modern constructive notice and marking provisions, rather than applying the 1870 text directly.
For pharmaceutical and health law research, the term "labeling" under FDA regulatory authority is expansive: it includes not only physical package labels but all written, printed, or graphic matter accompanying a product, including promotional materials. This broader definition is a frequent research trap — courts and agencies have repeatedly held that labeling obligations extend well beyond what is physically affixed to the container.
Jurisdictional variation is modest at the federal level for drugs and patents (both are federally preempted fields), but state labeling requirements for food, agricultural products, and consumer goods create a layered landscape. Preemption disputes between state and federal label laws have generated substantial litigation, particularly in the food and supplement sectors.
---
Historical Dictionary Support
Bouvier's Law Dictionary defines label laws exclusively through the patent marking lens, citing the Act of July 8, 1870. The entry correctly identifies the core rule: failure to mark forfeits damages unless the patentee proves the infringer received actual notice and continued infringing thereafter. This remains a fair summary of the marking penalty's structure, though the specific statutory cite is no longer current law.
What Bouvier does not address — and what no nineteenth-century legal dictionary could address — is the regulatory labeling apparatus that dominates the term in modern usage. The food and drug labeling framework, the FDA's authority over drug labeling approval, and the legal consequences of off-label promotion did not exist in Bouvier's era. Researchers should treat the Bouvier entry as an accurate but narrow historical snapshot, not a working definition for modern regulatory research.
---
Jurisdictional Note
Patent marking requirements are creatures of federal law and apply uniformly across U.S. jurisdictions. Pharmaceutical labeling is preempted by federal law under the FDCA for FDA-approved drugs, though the scope of preemption for failure-to-warn claims remains contested and varies by product category. State-level labeling laws for food, alcohol, and consumer products add complexity in jurisdictions with active consumer protection legislation.
---
Encyclopedia Cross-Reference
FDA Drug Approval — The New Drug Application Process, Clinical Trials, and Off-Label Use (Law Mind Health Law & Bioethics Encyclopedia): Directly relevant to the pharmaceutical labeling dimension of label laws, including approved labeling requirements, the legal consequences of off-label promotion, and the FDA's role in reviewing and authorizing drug label content.
---